UroAv-81 (AvKARE, Inc.)
Welcome to the PulseAid listing for the UroAv-81 drug offered from AvKARE, Inc.. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
| NON-PROPRIETARY NAME: | Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine Sulfate |
| SUBSTANCE NAME: | METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2016-02-02 |
| END MARKETING DATE: | 0000-00-00 |
UroAv-81 HUMAN PRESCRIPTION DRUG Details:
| Item Description | UroAv-81 from AvKARE, Inc. |
| LABELER NAME: | AvKARE, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 81; 40.8; 32.4; 10.8; .12(mg/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2016-02-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42291-851_a3b763ae-903e-e88e-ce6e-0bd9d85776d7 |
| PRODUCT NDC: | 42291-851 |
| APPLICATION NUMBER: | |
Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
